Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Revista
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
MAbs ; 15(1): 2160229, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36788124

RESUMO

TrYbe® is an Fc-free therapeutic antibody format, capable of engaging up to three targets simultaneously, with long in vivo half-life conferred by albumin binding. This format is shown by small-angle X-ray scattering to be conformationally flexible with favorable 'reach' properties. We demonstrate the format's broad functionality by co-targeting of soluble and cell surface antigens. The benefit of monovalent target binding is illustrated by the lack of formation of large immune complexes when co-targeting multivalent antigens. TrYbes® are manufactured using standard mammalian cell culture and protein A affinity capture processes. TrYbes® have been formulated at high concentrations and have favorable drug-like properties, including stability, solubility, and low viscosity. The unique functionality and inherent developability of the TrYbe® makes it a promising multi-specific antibody fragment format for antibody therapy.


Assuntos
Fragmentos Fc das Imunoglobulinas , Fragmentos de Imunoglobulinas , Animais , Meia-Vida , Fragmentos Fc das Imunoglobulinas/química , Mamíferos/metabolismo
2.
MAbs ; 8(7): 1319-1335, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27532598

RESUMO

An antibody format, termed Fab-dsFv, has been designed for clinical indications that require monovalent target binding in the absence of direct Fc receptor (FcR) binding while retaining substantial serum presence. The variable fragment (Fv) domain of a humanized albumin-binding antibody was fused to the C-termini of Fab constant domains, such that the VL and VH domains were individually connected to the Cκ and CH1 domains by peptide linkers, respectively. The anti-albumin Fv was selected for properties thought to be desirable to ensure a durable serum half-life mediated via FcRn. The Fv domain was further stabilized by an inter-domain disulfide bond. The bispecific format was shown to be thermodynamically and biophysically stable, and retained good affinity and efficacy to both antigens simultaneously. In in vivo studies, the serum half-life of Fab-dsFv, 2.6 d in mice and 7.9 d in cynomolgus monkeys, was equivalent to Fab'-PEG.


Assuntos
Anticorpos Biespecíficos/sangue , Fragmentos Fab das Imunoglobulinas , Região Variável de Imunoglobulina , Albumina Sérica/metabolismo , Animais , Anticorpos Biespecíficos/química , Anticorpos Biespecíficos/imunologia , Meia-Vida , Humanos , Fragmentos Fab das Imunoglobulinas/sangue , Fragmentos Fab das Imunoglobulinas/química , Região Variável de Imunoglobulina/sangue , Região Variável de Imunoglobulina/química , Camundongos , Albumina Sérica/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA